Redefine 1 trial finds cagrilintidesemaglutide combo delivers over 20% weight loss in majority of patients Summary: The Phase IIIa REDEFINE 1 trial found that once-weekly CagriSema produced unprecedented weight reductions in adults with overweight or obesity, with 60% achieving 20% weight loss and 23% losing 30% or more
Anticoagulant-induced skin necrosis Certain blood thinners, such as warfarin, can cause anticoagulant-induced skin necrosis
Cost of Mounjaro For individuals without insurance coverage, the Mounjaro cost with insurance might be prohibitively high, often ranging from $1,000 to $1,200 monthly
Why Retatrutide Could Be the Next Growth Driver for LLY On Monday, June 8, LLY shares opened with a 2.5% gap up following the release of full Phase 3 clinical trial results for Retatrutide
Shipping Ships from Ontario, Canada Availability is shown on this page For additional options, view research products available in Canada.
Bivalent binding and signaling characteristics of Leridistim, a novel chimeric dual agonist of interleukin-3 and granulocyte colony-stimulating factor receptors
